Share Price and Basic Stock Data
Last Updated: April 10, 2025, 12:39 pm
PEG Ratio | 1.62 |
---|
Competitors of Cera Sanitaryware Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Exxaro Tiles Ltd | 281 Cr. | 6.27 | 12.0/5.30 | 6.09 | 0.00 % | 4.54 % | 0.72 % | 1.00 | |
Carysil Ltd | 1,698 Cr. | 598 | 989/482 | 28.0 | 174 | 0.33 % | 17.1 % | 17.6 % | 2.00 |
Somany Ceramics Ltd | 1,728 Cr. | 421 | 873/395 | 25.2 | 180 | 0.71 % | 14.4 % | 12.9 % | 2.00 |
Orient Bell Ltd | 369 Cr. | 252 | 447/215 | 73.8 | 213 | 0.20 % | 0.97 % | 0.34 % | 10.0 |
Nitco Ltd | 802 Cr. | 112 | 149/58.0 | 82.2 | 0.00 % | 14.0 % | % | 10.0 | |
Industry Average | 2,832.56 Cr | 771.03 | 81.20 | 191.13 | 0.54% | 11.54% | 19.41% | 6.10 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 387 | 439 | 396 | 414 | 456 | 533 | 427 | 461 | 437 | 547 | 398 | 490 | 449 |
Expenses | 326 | 356 | 335 | 348 | 383 | 445 | 358 | 387 | 377 | 455 | 342 | 420 | 390 |
Operating Profit | 61 | 82 | 61 | 66 | 73 | 88 | 68 | 74 | 59 | 92 | 56 | 70 | 59 |
OPM % | 16% | 19% | 15% | 16% | 16% | 17% | 16% | 16% | 14% | 17% | 14% | 14% | 13% |
Other Income | 4 | 0 | -0 | 11 | 14 | 5 | 16 | 11 | 16 | 16 | 16 | 18 | 12 |
Interest | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 3 | 2 |
Depreciation | 8 | 8 | 7 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 8 | 10 | 10 |
Profit before tax | 56 | 73 | 53 | 68 | 77 | 83 | 75 | 76 | 65 | 98 | 63 | 75 | 60 |
Tax % | 25% | 29% | 25% | 25% | 27% | 25% | 25% | 25% | 22% | 23% | 25% | 10% | 23% |
Net Profit | 42 | 52 | 40 | 51 | 56 | 63 | 56 | 57 | 51 | 75 | 47 | 68 | 46 |
EPS in Rs | 32.50 | 40.04 | 30.47 | 39.00 | 43.34 | 48.39 | 43.34 | 43.74 | 39.12 | 57.69 | 36.11 | 52.35 | 35.26 |
Last Updated: February 28, 2025, 8:21 pm
Below is a detailed analysis of the quarterly data for Cera Sanitaryware Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is 449.00 Cr.. The value appears to be declining and may need further review. It has decreased from 490.00 Cr. (Sep 2024) to 449.00 Cr., marking a decrease of 41.00 Cr..
- For Expenses, as of Dec 2024, the value is 390.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 420.00 Cr. (Sep 2024) to 390.00 Cr., marking a decrease of 30.00 Cr..
- For Operating Profit, as of Dec 2024, the value is 59.00 Cr.. The value appears to be declining and may need further review. It has decreased from 70.00 Cr. (Sep 2024) to 59.00 Cr., marking a decrease of 11.00 Cr..
- For OPM %, as of Dec 2024, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 14.00% (Sep 2024) to 13.00%, marking a decrease of 1.00%.
- For Other Income, as of Dec 2024, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Sep 2024) to 12.00 Cr., marking a decrease of 6.00 Cr..
- For Interest, as of Dec 2024, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Sep 2024) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Dec 2024, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 10.00 Cr..
- For Profit before tax, as of Dec 2024, the value is 60.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Sep 2024) to 60.00 Cr., marking a decrease of 15.00 Cr..
- For Tax %, as of Dec 2024, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from 10.00% (Sep 2024) to 23.00%, marking an increase of 13.00%.
- For Net Profit, as of Dec 2024, the value is 46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Sep 2024) to 46.00 Cr., marking a decrease of 22.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 35.26. The value appears to be declining and may need further review. It has decreased from 52.35 (Sep 2024) to 35.26, marking a decrease of 17.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 4:36 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 488 | 664 | 822 | 917 | 1,011 | 1,182 | 1,344 | 1,209 | 1,202 | 1,442 | 1,803 | 1,871 | 1,884 |
Expenses | 412 | 569 | 703 | 776 | 841 | 1,014 | 1,152 | 1,045 | 1,052 | 1,220 | 1,510 | 1,577 | 1,607 |
Operating Profit | 76 | 95 | 119 | 141 | 171 | 168 | 191 | 164 | 150 | 221 | 293 | 295 | 277 |
OPM % | 16% | 14% | 14% | 15% | 17% | 14% | 14% | 14% | 12% | 15% | 16% | 16% | 15% |
Other Income | 9 | 6 | 5 | 10 | 11 | 14 | 15 | 14 | 22 | 17 | 25 | 59 | 63 |
Interest | 7 | 6 | 8 | 5 | 5 | 5 | 3 | 4 | 4 | 5 | 5 | 5 | 7 |
Depreciation | 9 | 12 | 15 | 16 | 18 | 22 | 23 | 33 | 33 | 30 | 30 | 34 | 37 |
Profit before tax | 68 | 82 | 101 | 129 | 158 | 154 | 180 | 141 | 134 | 203 | 282 | 314 | 296 |
Tax % | 32% | 37% | 33% | 36% | 34% | 35% | 36% | 18% | 25% | 27% | 26% | 24% | |
Net Profit | 46 | 52 | 68 | 83 | 104 | 100 | 115 | 116 | 101 | 149 | 210 | 239 | 236 |
EPS in Rs | 36.52 | 41.02 | 52.02 | 64.17 | 79.94 | 77.08 | 88.46 | 89.14 | 77.89 | 114.84 | 161.20 | 183.89 | 181.41 |
Dividend Payout % | 11% | 12% | 12% | 14% | 15% | 16% | 15% | 15% | 17% | 30% | 31% | 33% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 13.04% | 30.77% | 22.06% | 25.30% | -3.85% | 15.00% | 0.87% | -12.93% | 47.52% | 40.94% | 13.81% |
Change in YoY Net Profit Growth (%) | 0.00% | 17.73% | -8.71% | 3.24% | -29.15% | 18.85% | -14.13% | -13.80% | 60.46% | -6.59% | -27.13% |
Cera Sanitaryware Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 7% |
3 Years: | 16% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 16% |
5 Years: | 16% |
3 Years: | 33% |
TTM: | 2% |
Stock Price CAGR | |
---|---|
10 Years: | 7% |
5 Years: | 19% |
3 Years: | 4% |
1 Year: | -24% |
Return on Equity | |
---|---|
10 Years: | 18% |
5 Years: | 17% |
3 Years: | 18% |
Last Year: | 19% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 15, 2024, 1:32 am
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 173 | 218 | 345 | 415 | 518 | 598 | 694 | 766 | 868 | 999 | 1,163 | 1,336 | 1,213 |
Borrowings | 61 | 48 | 68 | 35 | 34 | 24 | 18 | 33 | 28 | 37 | 46 | 40 | 61 |
Other Liabilities | 139 | 181 | 224 | 290 | 302 | 320 | 371 | 320 | 381 | 385 | 441 | 443 | 422 |
Total Liabilities | 380 | 453 | 644 | 747 | 861 | 949 | 1,089 | 1,126 | 1,283 | 1,427 | 1,656 | 1,825 | 1,702 |
Fixed Assets | 125 | 152 | 215 | 226 | 266 | 279 | 305 | 350 | 330 | 321 | 320 | 356 | 384 |
CWIP | 4 | 5 | 8 | 4 | 0 | 5 | 11 | 1 | 1 | 1 | 17 | 13 | 4 |
Investments | 1 | 12 | 48 | 67 | 119 | 139 | 212 | 262 | 513 | 567 | 669 | 807 | 644 |
Other Assets | 249 | 284 | 374 | 449 | 475 | 525 | 561 | 512 | 440 | 539 | 649 | 649 | 670 |
Total Assets | 380 | 453 | 644 | 747 | 861 | 949 | 1,089 | 1,126 | 1,283 | 1,427 | 1,656 | 1,825 | 1,702 |
Below is a detailed analysis of the balance sheet data for Cera Sanitaryware Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹1,213.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,336.00 Cr. (Mar 2024) to ₹1,213.00 Cr., marking a decrease of 123.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹61.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 40.00 Cr. (Mar 2024) to ₹61.00 Cr., marking an increase of 21.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹422.00 Cr.. The value appears to be improving (decreasing). It has decreased from 443.00 Cr. (Mar 2024) to ₹422.00 Cr., marking a decrease of 21.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹1,702.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,825.00 Cr. (Mar 2024) to ₹1,702.00 Cr., marking a decrease of 123.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹384.00 Cr.. The value appears strong and on an upward trend. It has increased from 356.00 Cr. (Mar 2024) to ₹384.00 Cr., marking an increase of 28.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2024) to ₹4.00 Cr., marking a decrease of 9.00 Cr..
- For Investments, as of Sep 2024, the value is ₹644.00 Cr.. The value appears to be declining and may need further review. It has decreased from 807.00 Cr. (Mar 2024) to ₹644.00 Cr., marking a decrease of 163.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹670.00 Cr.. The value appears strong and on an upward trend. It has increased from 649.00 Cr. (Mar 2024) to ₹670.00 Cr., marking an increase of 21.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹1,702.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,825.00 Cr. (Mar 2024) to ₹1,702.00 Cr., marking a decrease of 123.00 Cr..
Notably, the Reserves (1,213.00 Cr.) exceed the Borrowings (61.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 15.00 | 47.00 | 51.00 | 106.00 | 137.00 | 144.00 | 173.00 | 131.00 | 122.00 | 184.00 | 247.00 | 255.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 62 | 59 | 72 | 75 | 80 | 83 | 81 | 67 | 63 | 42 | 38 | 39 |
Inventory Days | 160 | 125 | 120 | 109 | 98 | 104 | 101 | 128 | 96 | 154 | 167 | 148 |
Days Payable | 47 | 45 | 46 | 48 | 58 | 50 | 53 | 52 | 81 | 104 | 93 | 75 |
Cash Conversion Cycle | 176 | 139 | 145 | 137 | 120 | 136 | 129 | 142 | 78 | 92 | 112 | 112 |
Working Capital Days | 64 | 52 | 63 | 55 | 53 | 64 | 63 | 73 | 30 | 43 | 48 | 48 |
ROCE % | 35% | 35% | 32% | 30% | 31% | 26% | 27% | 19% | 16% | 22% | 26% | 25% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Canara Robeco Small Cap Fund | 218,823 | 1.63 | 195.48 | N/A | N/A | N/A |
ITI Multi Cap Fund | 18,123 | 1.19 | 16.19 | N/A | N/A | N/A |
Sundaram Small Cap Fund | 11,242 | 0.29 | 10.04 | N/A | N/A | N/A |
LIC MF ULIS 10 Yrs Regular Premium Reducing cover | 7,544 | 1.28 | 6.74 | N/A | N/A | N/A |
LIC MF ULIS 10 Yrs Regular Premium Uniform cover | 7,544 | 1.28 | 6.74 | N/A | N/A | N/A |
LIC MF ULIS 10 Yrs Single Premium | 7,544 | 1.28 | 6.74 | N/A | N/A | N/A |
LIC MF ULIS 15 Yrs Regular Premium Reducing cover | 7,544 | 1.28 | 6.74 | N/A | N/A | N/A |
LIC MF ULIS 15 Yrs Regular Premium Uniform cover | 7,544 | 1.28 | 6.74 | N/A | N/A | N/A |
LIC MF ULIS 5 Years Single Premium | 7,544 | 1.28 | 6.74 | N/A | N/A | N/A |
Canara Robeco Conservative Hybrid Fund | 3,600 | 0.38 | 3.66 | N/A | N/A | N/A |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Basic EPS (Rs.) | 183.76 | 161.01 | 116.18 | 77.48 | 87.08 |
Diluted EPS (Rs.) | 183.76 | 161.01 | 116.18 | 77.48 | 87.08 |
Cash EPS (Rs.) | 213.65 | 187.35 | 142.51 | 107.24 | 114.80 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 1044.56 | 909.79 | 791.48 | 679.28 | 598.52 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 1044.56 | 909.79 | 791.48 | 679.28 | 598.52 |
Revenue From Operations / Share (Rs.) | 1445.06 | 1386.69 | 1111.68 | 941.37 | 940.88 |
PBDIT / Share (Rs.) | 278.93 | 252.61 | 194.05 | 140.87 | 141.24 |
PBIT / Share (Rs.) | 250.83 | 227.54 | 169.13 | 110.45 | 111.43 |
PBT / Share (Rs.) | 245.16 | 219.04 | 160.66 | 102.97 | 103.70 |
Net Profit / Share (Rs.) | 185.55 | 162.27 | 117.60 | 76.82 | 84.99 |
NP After MI And SOA / Share (Rs.) | 183.77 | 161.01 | 116.18 | 77.48 | 87.08 |
PBDIT Margin (%) | 19.30 | 18.21 | 17.45 | 14.96 | 15.01 |
PBIT Margin (%) | 17.35 | 16.40 | 15.21 | 11.73 | 11.84 |
PBT Margin (%) | 16.96 | 15.79 | 14.45 | 10.93 | 11.02 |
Net Profit Margin (%) | 12.84 | 11.70 | 10.57 | 8.16 | 9.03 |
NP After MI And SOA Margin (%) | 12.71 | 11.61 | 10.45 | 8.23 | 9.25 |
Return on Networth / Equity (%) | 17.75 | 17.85 | 14.88 | 11.56 | 14.69 |
Return on Capital Employeed (%) | 22.26 | 23.06 | 19.66 | 14.29 | 16.05 |
Return On Assets (%) | 12.95 | 12.48 | 9.73 | 7.31 | 9.28 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
Total Debt / Equity (X) | 0.01 | 0.02 | 0.02 | 0.05 | 0.08 |
Asset Turnover Ratio (%) | 1.07 | 1.12 | 1.03 | 0.96 | 1.04 |
Current Ratio (X) | 3.74 | 3.24 | 2.68 | 2.42 | 2.28 |
Quick Ratio (X) | 2.79 | 2.27 | 2.01 | 1.88 | 1.51 |
Inventory Turnover Ratio (X) | 0.67 | 0.76 | 0.72 | 0.41 | 0.49 |
Dividend Payout Ratio (NP) (%) | 27.20 | 21.73 | 11.18 | 0.00 | 29.85 |
Dividend Payout Ratio (CP) (%) | 23.59 | 18.80 | 9.21 | 0.00 | 22.24 |
Earning Retention Ratio (%) | 72.80 | 78.27 | 88.82 | 0.00 | 70.15 |
Cash Earning Retention Ratio (%) | 76.41 | 81.20 | 90.79 | 0.00 | 77.76 |
Interest Coverage Ratio (X) | 62.32 | 54.32 | 47.79 | 18.83 | 18.28 |
Interest Coverage Ratio (Post Tax) (X) | 42.72 | 36.72 | 31.05 | 11.27 | 12.00 |
Enterprise Value (Cr.) | 8811.02 | 8314.10 | 6496.10 | 5152.10 | 3091.84 |
EV / Net Operating Revenue (X) | 4.69 | 4.61 | 4.49 | 4.21 | 2.53 |
EV / EBITDA (X) | 24.29 | 25.31 | 25.74 | 28.12 | 16.83 |
MarketCap / Net Operating Revenue (X) | 4.69 | 4.60 | 4.47 | 4.15 | 2.45 |
Retention Ratios (%) | 72.79 | 78.26 | 88.81 | 0.00 | 70.14 |
Price / BV (X) | 6.55 | 7.08 | 6.37 | 5.83 | 3.89 |
Price / Net Operating Revenue (X) | 4.69 | 4.60 | 4.47 | 4.15 | 2.45 |
EarningsYield | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 |
After reviewing the key financial ratios for Cera Sanitaryware Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 183.76. This value is within the healthy range. It has increased from 161.01 (Mar 23) to 183.76, marking an increase of 22.75.
- For Diluted EPS (Rs.), as of Mar 24, the value is 183.76. This value is within the healthy range. It has increased from 161.01 (Mar 23) to 183.76, marking an increase of 22.75.
- For Cash EPS (Rs.), as of Mar 24, the value is 213.65. This value is within the healthy range. It has increased from 187.35 (Mar 23) to 213.65, marking an increase of 26.30.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,044.56. It has increased from 909.79 (Mar 23) to 1,044.56, marking an increase of 134.77.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,044.56. It has increased from 909.79 (Mar 23) to 1,044.56, marking an increase of 134.77.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 1,445.06. It has increased from 1,386.69 (Mar 23) to 1,445.06, marking an increase of 58.37.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 278.93. This value is within the healthy range. It has increased from 252.61 (Mar 23) to 278.93, marking an increase of 26.32.
- For PBIT / Share (Rs.), as of Mar 24, the value is 250.83. This value is within the healthy range. It has increased from 227.54 (Mar 23) to 250.83, marking an increase of 23.29.
- For PBT / Share (Rs.), as of Mar 24, the value is 245.16. This value is within the healthy range. It has increased from 219.04 (Mar 23) to 245.16, marking an increase of 26.12.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 185.55. This value is within the healthy range. It has increased from 162.27 (Mar 23) to 185.55, marking an increase of 23.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 183.77. This value is within the healthy range. It has increased from 161.01 (Mar 23) to 183.77, marking an increase of 22.76.
- For PBDIT Margin (%), as of Mar 24, the value is 19.30. This value is within the healthy range. It has increased from 18.21 (Mar 23) to 19.30, marking an increase of 1.09.
- For PBIT Margin (%), as of Mar 24, the value is 17.35. This value is within the healthy range. It has increased from 16.40 (Mar 23) to 17.35, marking an increase of 0.95.
- For PBT Margin (%), as of Mar 24, the value is 16.96. This value is within the healthy range. It has increased from 15.79 (Mar 23) to 16.96, marking an increase of 1.17.
- For Net Profit Margin (%), as of Mar 24, the value is 12.84. This value exceeds the healthy maximum of 10. It has increased from 11.70 (Mar 23) to 12.84, marking an increase of 1.14.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 12.71. This value is within the healthy range. It has increased from 11.61 (Mar 23) to 12.71, marking an increase of 1.10.
- For Return on Networth / Equity (%), as of Mar 24, the value is 17.75. This value is within the healthy range. It has decreased from 17.85 (Mar 23) to 17.75, marking a decrease of 0.10.
- For Return on Capital Employeed (%), as of Mar 24, the value is 22.26. This value is within the healthy range. It has decreased from 23.06 (Mar 23) to 22.26, marking a decrease of 0.80.
- For Return On Assets (%), as of Mar 24, the value is 12.95. This value is within the healthy range. It has increased from 12.48 (Mar 23) to 12.95, marking an increase of 0.47.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.07. It has decreased from 1.12 (Mar 23) to 1.07, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 24, the value is 3.74. This value exceeds the healthy maximum of 3. It has increased from 3.24 (Mar 23) to 3.74, marking an increase of 0.50.
- For Quick Ratio (X), as of Mar 24, the value is 2.79. This value exceeds the healthy maximum of 2. It has increased from 2.27 (Mar 23) to 2.79, marking an increase of 0.52.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.67. This value is below the healthy minimum of 4. It has decreased from 0.76 (Mar 23) to 0.67, marking a decrease of 0.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 27.20. This value is within the healthy range. It has increased from 21.73 (Mar 23) to 27.20, marking an increase of 5.47.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 23.59. This value is within the healthy range. It has increased from 18.80 (Mar 23) to 23.59, marking an increase of 4.79.
- For Earning Retention Ratio (%), as of Mar 24, the value is 72.80. This value exceeds the healthy maximum of 70. It has decreased from 78.27 (Mar 23) to 72.80, marking a decrease of 5.47.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 76.41. This value exceeds the healthy maximum of 70. It has decreased from 81.20 (Mar 23) to 76.41, marking a decrease of 4.79.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 62.32. This value is within the healthy range. It has increased from 54.32 (Mar 23) to 62.32, marking an increase of 8.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 42.72. This value is within the healthy range. It has increased from 36.72 (Mar 23) to 42.72, marking an increase of 6.00.
- For Enterprise Value (Cr.), as of Mar 24, the value is 8,811.02. It has increased from 8,314.10 (Mar 23) to 8,811.02, marking an increase of 496.92.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.69. This value exceeds the healthy maximum of 3. It has increased from 4.61 (Mar 23) to 4.69, marking an increase of 0.08.
- For EV / EBITDA (X), as of Mar 24, the value is 24.29. This value exceeds the healthy maximum of 15. It has decreased from 25.31 (Mar 23) to 24.29, marking a decrease of 1.02.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.69. This value exceeds the healthy maximum of 3. It has increased from 4.60 (Mar 23) to 4.69, marking an increase of 0.09.
- For Retention Ratios (%), as of Mar 24, the value is 72.79. This value exceeds the healthy maximum of 70. It has decreased from 78.26 (Mar 23) to 72.79, marking a decrease of 5.47.
- For Price / BV (X), as of Mar 24, the value is 6.55. This value exceeds the healthy maximum of 3. It has decreased from 7.08 (Mar 23) to 6.55, marking a decrease of 0.53.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.69. This value exceeds the healthy maximum of 3. It has increased from 4.60 (Mar 23) to 4.69, marking an increase of 0.09.
- For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cera Sanitaryware Ltd:
- Net Profit Margin: 12.84%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.26% (Industry Average ROCE: 11.54%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.75% (Industry Average ROE: 19.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 42.72
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.79
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 29.8 (Industry average Stock P/E: 81.2)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.84%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Ceramics/Tiles/Sanitaryware | 9, GIDC Industrial Estate, Kadi, Mehsana Dist. Gujarat 382715 | kadi@cera-india.com http://www.cera-india.com |
Management | |
---|---|
Name | Position Held |
Mr. Vikram Somany | Chairman & Managing Director |
Mrs. Deepshikha Khaitan | Joint Managing Director |
Mr. Anupam Gupta | Executive Director -Technical |
Mr. Surendra Singh Baid | Independent Director |
Ms. Akriti Jain | Independent Director |
Mr. Ravi Bhamidipaty | Independent Director |
Mr. Anandh Sundar | Independent Director |
FAQ
What is the intrinsic value of Cera Sanitaryware Ltd?
Cera Sanitaryware Ltd's intrinsic value (as of 13 April 2025) is ₹4295.93 — 20.64% lower the current market price of 5,413.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,040 Cr. market cap, FY2025-2026 high/low of ₹11,500/5,060, reserves of 1,213 Cr, and liabilities of 1,702 Cr.
What is the Market Cap of Cera Sanitaryware Ltd?
The Market Cap of Cera Sanitaryware Ltd is 7,040 Cr..
What is the current Stock Price of Cera Sanitaryware Ltd as on 13 April 2025?
The current stock price of Cera Sanitaryware Ltd as on 13 April 2025 is 5,413.
What is the High / Low of Cera Sanitaryware Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cera Sanitaryware Ltd stocks is ₹11,500/5,060.
What is the Stock P/E of Cera Sanitaryware Ltd?
The Stock P/E of Cera Sanitaryware Ltd is 29.8.
What is the Book Value of Cera Sanitaryware Ltd?
The Book Value of Cera Sanitaryware Ltd is 938.
What is the Dividend Yield of Cera Sanitaryware Ltd?
The Dividend Yield of Cera Sanitaryware Ltd is 1.11 %.
What is the ROCE of Cera Sanitaryware Ltd?
The ROCE of Cera Sanitaryware Ltd is 24.6 %.
What is the ROE of Cera Sanitaryware Ltd?
The ROE of Cera Sanitaryware Ltd is 19.0 %.
What is the Face Value of Cera Sanitaryware Ltd?
The Face Value of Cera Sanitaryware Ltd is 5.00.